NSE:CONCORDBIO
Concord Biotech Limited · NSE · Healthcare · INR · FY for 2026
Figures on this page computed 2026-11-08 13:29 UTC
Last close
n/aINR
Market data
51.1xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- INR
- computed
- Computed from the filing for 2026
11.0%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
24.7%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
16.5%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
0.001Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
0.8%Dividend yield
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- INR
- computed
Price is the furthest below its sector's middle: 0.13 against 0.36 on the market's range.
Five bars, one line
lens 7 of 9Each against its own average
4 of 5 readExcept where said otherwise: Computed from the filing for 2026
- Sales1.24x
Its own average over 7 years, 8.52B.
- Profit1.04x
Its own average over 7 years, 2.51B.
- Free cash flow2.01x
Its own average over 7 years, 864.4M.
- Debt0.06x
Its own average over 7 years, 357.7M.
- Pricen/a
Its own average over 0 years. Market data
Free cash flow is furthest from its own average, at 2.01 times.
Sales is 1.24 times its own 7-year average; Profit is 1.04 times its own 7-year average; Free cash flow is 2.01 times its own 7-year average; Debt is 0.06 times its own 7-year average.
Every figure in this lens
Except where said otherwise: Computed from the filing for 2026
Sales against its own 7-year average1.24
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- INR
Profit against its own 7-year average1.04
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- INR
Free cash flow against its own 7-year average2.01
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- INR
Debt against its own 7-year average0.06
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- INR
Price against its own 0-year averagen/aMarket data
Not held.
- Source
- market
- Reported in
- INR